Somagenetix

BiotechnologySeries AZurich, Switzerlandsomagenetix.com

Latest round

Series A

Last raised

Oct 2024

Total raised

$12M

Investors

4

About Somagenetix

Based in Zurich, Switzerland, Somagenetix operates as a biotechnology company that develops gene therapies for phagocyte-related disorders, targeting immunodeficiency, neurodegeneration, and cancer through enhanced phagocyte treatments. Somagenetix is a developing biotech startup working to advance gene therapy for phagocyte abnormalities, with the goal of providing effective, one-time therapies for genetic disorders. The company's important approach employs lentivirus-transduced stem cells to ensure safety, specificity, and long-term efficacy, resulting in much better patient results. The team has experience with gene therapy and is dedicated to developing treatments for hereditary and neurological disorders.

Who invested in Somagenetix

4 investors across 1 round

See all investors in Somagenetix

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Oct 8, 2024

    Amount

    $12M

    Investors

    Locked

Questions about Somagenetix

Who invested in Somagenetix?

Somagenetix has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Somagenetix raised?

Somagenetix has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Somagenetix last raise money?

Somagenetix's most recent round on record is a Series A, in Oct 2024.

What does Somagenetix do?

Based in Zurich, Switzerland, Somagenetix operates as a biotechnology company that develops gene therapies for phagocyte-related disorders, targeting immunodeficiency, neurodegeneration, and cancer through enhanced phagocyte treatments.

Where is Somagenetix headquartered?

Somagenetix is headquartered in Zurich, Switzerland.

Which VCs invest in companies like Somagenetix?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Somagenetix's stage. Their profiles are linked below.

Raising like Somagenetix? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.